Hong Kong's biotechnology stocks surged across the board, led by the WUXI group, with WUXI BIO rising more than 9%.

Breakings · 01:49

Hong Kong stock biotechnology stocks surged across the board, with WUXI BIO rising over 9%, WUXI XDC increasing more than 6%, WUXI APPTEC and Kelun Biotech rising over 4%, and TIGERMED and JUNSHI BIO gaining over 3%.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

Views 40.6k

Recommended

What is this signal? Buffett, who rarely sells controlling businesses, is rumored to be negotiating to sell Assets.

cls.cn · Mar 14, 2025 11:44
Report: Tesla will launch a "Low Stock Price" version of the Model Y next year, reducing costs by 20% to defend its market share i…

wallstreetcn · Mar 14, 2025 10:24
The US stock market is once again focused on Jensen Huang! NVIDIA's next-generation AI GPU is about to be spectacularly rel…

Wind · Mar 14, 2025 11:31
A glimpse ahead | Tencent will release its Q4 Earnings Reports next week! With both Gaming and Advertising Businesses maki…

Futu News · Mar 14, 2025 09:31
Bank of America reveals the motivation behind Trump's reform: one-third of GDP comes from fiscal expenditure, and 85% of ne…

wallstreetcn · Mar 14, 2025 10:58

Write a comment

港股生物技术股全线冲高，药明系领涨，药明生物大涨逾9%

Hong Kong's biotechnology stocks surged across the board, led by the WUXI group, with WUXI BIO rising more than 9%.

Risk Disclaimer

Statement